Skip to content
lifestyle.cleanweb.co
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
LB Pharmaceuticals Inc
LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
October 10, 2026
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
October 9, 2026
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
October 6, 2026
LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
September 15, 2026
LB Pharmaceuticals to Participate in Upcoming September Investor Events
September 3, 2026
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer
September 3, 2026
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
LB Pharmaceuticals Announces $150 Million Private Placement
July 29, 2026
LB Pharmaceuticals to Participate in Upcoming June Investor Events
May 28, 2026
LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026
1
2
Next Page
→